Tony is the trailblazer behind the cutting edge work at the world’s largest proteomics center, accelerating biomarker discoveries to enable patients to be treated in an individual way, at the right time, for the best outcome.
Tony originally trained in biochemistry before pursuing research in hematology and stem cell biology, successfully pioneering new mass spectrometry techniques and state-of-the-art facilities. His research then expanded and developed to include clinical proteomics research to discover new biomarkers associated with cancers.
Under his expert leadership at the Stoller Biomarker Discovery Centre (founded in partnership with SCIEX), researchers will help to industrialize the process of identifying biomarkers—proteins that indicate the presence of a disease, such as cancer and arthritis, or the likelihood that a patient will respond to a specific therapy for their disease.
“We aim to find protein markers in the blood that could be used to stop patients being given treatments which won’t improve their condition. These markers will be developed to ensure doctors can prescribe the right treatment for the right patient as early as possible. The Centre is a major step forward in precision medicine and the future of healthcare.”